PARATI, GIANFRANCO
 Distribuzione geografica
Continente #
NA - Nord America 58.175
EU - Europa 23.425
AS - Asia 10.862
SA - Sud America 228
AF - Africa 80
OC - Oceania 73
Continente sconosciuto - Info sul continente non disponibili 43
Totale 92.886
Nazione #
US - Stati Uniti d'America 57.320
CN - Cina 4.165
IE - Irlanda 4.043
SE - Svezia 4.017
IT - Italia 3.774
DE - Germania 3.388
SG - Singapore 3.316
RU - Federazione Russa 2.585
UA - Ucraina 2.243
HK - Hong Kong 1.871
GB - Regno Unito 1.222
CA - Canada 797
FI - Finlandia 664
VN - Vietnam 534
FR - Francia 398
IN - India 247
TR - Turchia 206
NL - Olanda 205
AT - Austria 200
DK - Danimarca 199
ID - Indonesia 163
BE - Belgio 119
BR - Brasile 110
JP - Giappone 84
IR - Iran 61
AU - Australia 60
KR - Corea 56
ES - Italia 49
CZ - Repubblica Ceca 47
RO - Romania 47
PL - Polonia 46
PT - Portogallo 34
PE - Perù 31
CH - Svizzera 30
TH - Thailandia 29
EU - Europa 28
MX - Messico 28
CL - Cile 25
TW - Taiwan 23
GR - Grecia 21
AR - Argentina 20
BG - Bulgaria 20
HU - Ungheria 20
ZA - Sudafrica 20
BD - Bangladesh 17
CO - Colombia 16
MY - Malesia 13
NO - Norvegia 12
AE - Emirati Arabi Uniti 11
EG - Egitto 11
NZ - Nuova Zelanda 11
PK - Pakistan 11
A2 - ???statistics.table.value.countryCode.A2??? 10
BO - Bolivia 9
IL - Israele 9
VE - Venezuela 9
NG - Nigeria 8
AM - Armenia 7
KE - Kenya 7
SC - Seychelles 7
BB - Barbados 6
BY - Bielorussia 6
EC - Ecuador 6
NP - Nepal 6
PH - Filippine 6
SA - Arabia Saudita 6
DZ - Algeria 5
LK - Sri Lanka 5
LT - Lituania 5
AL - Albania 4
GE - Georgia 4
GT - Guatemala 4
HR - Croazia 4
JO - Giordania 4
PA - Panama 4
RS - Serbia 4
SI - Slovenia 4
A1 - Anonimo 3
CU - Cuba 3
DO - Repubblica Dominicana 3
EE - Estonia 3
GH - Ghana 3
MA - Marocco 3
MK - Macedonia 3
MU - Mauritius 3
AP - ???statistics.table.value.countryCode.AP??? 2
CM - Camerun 2
CR - Costa Rica 2
JM - Giamaica 2
LV - Lettonia 2
LY - Libia 2
MD - Moldavia 2
MG - Madagascar 2
PG - Papua Nuova Guinea 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UG - Uganda 2
VC - Saint Vincent e Grenadine 2
BJ - Benin 1
CY - Cipro 1
Totale 92.868
Città #
Ann Arbor 10.712
Fairfield 6.278
Woodbridge 4.686
Dublin 3.857
Chandler 3.818
Houston 3.708
Ashburn 3.116
Wilmington 2.971
Frankfurt am Main 2.713
Singapore 2.683
Jacksonville 2.604
Seattle 2.291
Cambridge 2.082
Dearborn 2.041
Hong Kong 1.847
New York 1.829
Princeton 1.739
Milan 1.048
Lawrence 833
Nanjing 793
Altamura 785
Beijing 571
Santa Clara 539
San Diego 500
Shanghai 435
Lachine 375
Dong Ket 303
Boardman 266
Hangzhou 259
Nanchang 243
Shenyang 237
Andover 235
Guangzhou 231
Toronto 195
Helsinki 190
Vienna 184
Hebei 180
London 158
Jakarta 153
Jiaxing 147
Norwalk 147
Ottawa 141
Tianjin 137
Changsha 124
Falls Church 118
Jinan 109
Brussels 108
Rome 94
Mountain View 86
Huizen 84
Lappeenranta 82
Fremont 76
Zhengzhou 76
Hefei 74
Los Angeles 72
Kunming 64
Detroit 63
Washington 60
Dallas 59
Chicago 58
Ningbo 55
Phoenix 51
Pune 43
Redmond 43
Saint Petersburg 43
Perugia 42
San Mateo 42
Taizhou 42
Kilburn 40
Edmonton 36
Moscow 36
Amsterdam 33
Brno 31
Sacramento 31
São Paulo 30
Bologna 29
Fuzhou 28
Chiswick 27
Groningen 27
Kiev 26
Munich 26
University Park 26
Wuhan 26
Clearwater 25
Bergamo 24
Bonndorf 24
Kraków 24
Leawood 24
Tokyo 24
Hounslow 23
Naples 22
San Francisco 22
Cinisello Balsamo 21
Turin 21
Verona 21
Taiyuan 19
Belo Horizonte 18
Berlin 18
Lissone 18
Upper Marlboro 18
Totale 70.846
Nome #
Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid-range ejection fraction 390
Changes in 24 h ambulatory blood pressure and effects of angiotensin II receptor blockade during acute and prolonged high-altitude exposure: A randomized clinical trial 377
May Measurement Month 2017: an analysis of blood pressure screening results worldwide 373
Endothelin-1/nitric oxide balance and HOMA index in children with excess weight and hypertension: a pathophysiological model of hypertension 349
The impact of systolic and diastolic blood pressure variability on mortality is age dependent: Data from the Dublin Outcome Study 341
Calmodulinopathy: A Novel, Life-Threatening Clinical Entity Affecting the Young 318
Effect of continuous positive airway pressure in hypertensive patients with obstructive sleep apnea and high urinary metanephrines 298
Nation-wide hypertension screening in Italy: data from May Measurements Month 2017-Europe 285
Comprehensive effects of left ventricular assist device speed changes on alveolar gas exchange, sleep ventilatory pattern, and exercise performance 277
Impact of obstructive sleep apnea on cardiac organ damage in patients with acute ischemic stroke 273
Aldosterone-To-renin ratio depends on age and sex in children attending a clinic for cardiovascular risk assessment 273
Nomograms to identify elevated blood pressure values and left ventricular hypertrophy in a paediatric population: American Academy of Pediatrics Clinical Practice vs. Fourth Report/European Society of Hypertension Guidelines 272
Calcium antagonists and neural control of circulation in essential hypertension 263
Effects of acute exposure to moderate altitude on blood pressure and sleep breathing patterns 256
Changes in 24 hour blood pressure and in cardiac and vascular structure in normotensive subjects with parental hypertension 254
Early 24-hour blood pressure elevation in normotensive subjects with parental hypertension 249
Effects of blood-pressure measurement by the doctor on patient's blood pressure and heart rate 249
Home blood pressure telemonitoring improves hypertension control in general practice. the TeleBPCare study 239
Morning blood pressure surge: pathophysiology, clinical relevance and therapeutic aspects 238
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2 237
European society of hypertension guidelines for blood pressure monitoring at home: A summary report of the second international consensus conference on home blood pressure monitoring 236
Clinical recommendations for high altitude exposure of individuals with pre-existing cardiovascular conditions: A joint statement by the european society of cardiology, the council on hypertension of the european society of cardiology, the european society of hypertension, the international society of mountain medicine, the Italian society of hypertension and the Italian society of mountain medicine 235
An ICT and mobile health integrated approach to optimize patients' education on hypertension and its management by physicians: The Patients Optimal Strategy of Treatment(POST) pilot study 233
Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study 233
Transthoracic bioimpedance and bnp assessment for prognostic stratification of outpatients with chronic systolic heart failure. 229
Blood pressure variability and obstructive sleep apnea. A question of phenotype? 226
Effects of celiprolol on reflex control of the cardiovascular system in essential hypertension 223
Cap. 8: Cuore e malattie sistemiche 217
Different effects of antihypertensive treatment on office and ambulatory blood pressure: Ameta-analysis 215
Evaluation of the baroreceptor-heart rate reflex by 24-hour intra-arterial blood pressure monitoring in humans 214
Role of T1 mapping as a complementary tool to T2* for non-invasive cardiac iron overload assessment 212
Effects of lifestyle modifications on elevated blood pressure and excess weight in a population of Italian children and adolescents 211
Pulsed intravenous methylprednisolone combined with oral steroids as a treatment for poorly responsive type 2 amiodarone-induced thyrotoxicosis 210
Improvement of functional capacity in sacubitril-valsartan treated patients assessed by cardiopulmonary exercise test 209
Blood pressure and heart rate variabilities in normotensive and hypertensive human beings 208
Twenty-four-hour blood pressure profile and blood pressure variability in untreated hypertension and during antihypertensive treatment by once-a-day nadolol 207
Pulmonary hypertension due to a stiff left atrium: Speckle tracking equivalents of large V-waves 207
Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years 207
Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: Meta-analysis of randomised controlled trials 205
Influence of cardiopulmonary receptors on the bradycardiac responses to carotid baroreceptor stimulation in man 205
Blood pressure response to labetalol in twice and three times daily administration during a 24‐hour period 202
Evaluation of a slow-release clonidine preparation by direct continuous blood pressure recording in essential hypertensive patients 199
Noninvasive Estimation of Aortic Stiffness Through Different Approaches: Comparison with Intra-Aortic Recordings 197
Mechanisms of antihypertensive action of beta-adrenergic blocking drugs: evidence against potentiation of baroreflexes 196
Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy 196
High altitude exposure of three weeks duration increases lung diffusing capacity in humans 196
Twenty-four-hour hemodynamic profile during treatment of essential hypertension by once-a-day nadolol 195
Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension 195
Modification of arterial baroreflexes by captopril in essential hypertension 194
Heart failure and anemia: Effects on prognostic variables 193
Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project 189
Control of circulation by arterial baroreceptors and cardiopulmonary receptors in hypertension 187
Validation of the Somnotouch-NIBP noninvasive continuous blood pressure monitor according to the European Society of Hypertension International Protocol revision 2010 186
Hemodynamic and Autonomic Response to Different Salt Intakes in Normotensive Individuals 183
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 183
Circulating factors are involved in hypoxia-induced hepcidin suppression 182
Sex and acetazolamide effects on chemoreflex and periodic breathing during sleep at altitude 182
[Are plasma catecholamine levels capable of reflecting even small variations in sympathetic activity?] 182
Alerting reaction and rise in blood pressure during measurement by physician and nurse 182
A randomized and controlled study of noninvasive hemodynamicmonitoring as a guide to drug treatment of uncontrolled hypertensive patients 181
Prognostic value of baroreflex sensitivity in heart failure. A 2018 reappraisal 181
Predicting Depression from Illness Severity in Cardiovascular Disease Patients: Self-efficacy Beliefs, Illness Perception, and Perceived Social Support as Mediators 181
Vascular Health Assessment of The Hypertensive Patients (VASOTENS) Registry: Study Protocol of an International, Web-Based Telemonitoring Registry for Ambulatory Blood Pressure and Arterial Stiffness 179
Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: A meta-analysis 179
Effects of device-guided slow breathing training on exercise capacity, cardiac function, and respiratory patterns during sleep in male and female patients with chronic heart failure 178
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison 177
Obstructive sleep apnoea treatment and blood pressure: Which phenotypes predict a response? A systematic review and meta-analysis 177
Effects of selective and nonselective beta-blockade on 24-h ambulatory blood pressure under hypobaric hypoxia at altitude 176
Recommendations and Practical Guidance for performing and reporting validation studies according to the Universal Standard for the validation of blood pressure measuring devices by the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) 176
Blood Pressure Response to Exercise in Hypertensive Subjects Exposed to High Altitude and Treatment Effects 175
The Added Value of 3-Dimensional Echocardiography to Understand the Pathophysiology of Functional Tricuspid Regurgitation 175
Effects of beta-blockade on exercise performance at high altitude: a randomized, placebo-controlled trial comparing the efficacy of nebivolol versus carvedilol in healthy subjects 174
Prevalence of hypertension and cardiovascular risk factors in chinese migrating to Milan as compared to a northern italian population 173
[Direct and continuous recording of arterial pressure in the diagnosis of pheochromocytoma] 173
Intra-aortic balloon pump for treatment of refractory ventricular tachycardia in Tako-Tsubo cardiomyopathy: A case report 172
Effects of hypobaric hypoxia exposure at high altitude on left ventricular twist in healthy subjects: Data from HIGHCARE study on Mount Everest 172
Role of acetazolamide and telmisartan/nifedipine-GITS combination in antagonizing the blood pressure rise induced by high altitude exposure 172
Periodic limb movements during sleep and blood pressure changes in sleep apnoea: Data from the European Sleep Apnoea Database 172
Randomized Controlled Trials of Blood Pressure Lowering in Hypertension: A Critical Reappraisal 171
Evaluation of relationship between cardio-ankle vascular index and 24h ambulatory blood pressure variables 170
Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study 170
Control of blood pressure by carotid sinus baroreceptors in human beings 170
Natriuretic peptides and cardiovascular variability 169
Determinants of different blood pressure variability indices in untreated hypertensive patients. Data from the Dublin study 169
Short-Term Repeatability of Noninvasive Aortic Pulse Wave Velocity Assessment: Comparison between Methods and Devices 169
Reduction of 24-h blood pressure variability in extreme obese patients 10 days and 6 months after bariatric surgery depending on pre-existing hypertension 169
Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study 168
Pulmonary congestion at rest and abnormal ventilation during exercise in chronic systolic heart failure 167
Clinical and psychological telemonitoring and telecare of high risk heart failure patients 166
Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: Rationale for further study on blood pressure targets of antihypertensive treatment after stroke 165
MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: A randomised controlled trial protocol 164
Neural Control of Circulation Before and After Intravenous Urapidil in Essential Hypertension 164
Exercise performance is a prognostic indicator in elderly patients with chronic heart failure: Application of metabolic exercise cardiac kidney indexes score 163
Intermittent levosimendan infusions in advanced heart failure: a real world experience 163
Levosimendan improves diastolic function and reduces the degree of functional mitral regurgitation in patients with moderate heart failure 162
High-altitude hypoxia and periodic breathing during sleep: gender related differences 162
Aging, High Altitude, and Blood Pressure: A Complex Relationship 162
A systematic reviewandmeta-analysis of randomized controlled trials investigating the effects of supplementationwith Nigella sativa (black seed) on blood pressure 162
Impaired central pulsatile hemodynamics in children and adolescents with Marfan syndrome 162
Effects of acetazolamide on central blood pressure, peripheral blood pressure, and arterial distensibility at acute high altitude exposure 161
Totale 20.763
Categoria #
all - tutte 360.436
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 360.436


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202013.440 0 0 1.059 1.328 1.410 2.086 2.143 1.330 1.571 1.005 1.074 434
2020/202115.317 967 759 1.600 1.602 1.140 1.364 1.581 1.547 1.371 1.428 737 1.221
2021/202211.977 750 1.116 1.755 955 812 626 659 684 634 798 1.160 2.028
2022/202316.265 2.161 4.384 1.536 1.295 1.065 2.714 208 845 1.064 196 448 349
2023/202412.180 352 463 432 498 1.785 3.168 2.304 306 1.110 223 207 1.332
2024/20256.589 1.930 3.850 809 0 0 0 0 0 0 0 0 0
Totale 96.516